Cargando…
HuRdling Senescence: HuR Breaks BRAF-Induced Senescence in Melanocytes and Supports Melanoma Growth
In addition to genetic changes, post-transcriptional events strongly contribute to the progression of malignant tumors. The RNA-binding protein HuR (ELAVL1) is able to bind and stabilize a large group of target mRNAs, which contain AU-rich elements (ARE) in their 3′-untranslated region. We found HuR...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281285/ https://www.ncbi.nlm.nih.gov/pubmed/32455577 http://dx.doi.org/10.3390/cancers12051299 |
_version_ | 1783543887662415872 |
---|---|
author | Liebig, Janika K. Kuphal, Silke Bosserhoff, Anja Katrin |
author_facet | Liebig, Janika K. Kuphal, Silke Bosserhoff, Anja Katrin |
author_sort | Liebig, Janika K. |
collection | PubMed |
description | In addition to genetic changes, post-transcriptional events strongly contribute to the progression of malignant tumors. The RNA-binding protein HuR (ELAVL1) is able to bind and stabilize a large group of target mRNAs, which contain AU-rich elements (ARE) in their 3′-untranslated region. We found HuR to be upregulated in malignant melanoma in vitro and in vivo, significantly correlating with progression in vivo. Additionally, we could show that miR-194-5p can regulate HuR expression level. HuR knockdown in melanoma cells led to the suppression of proliferation and the induction of cellular senescence. Interestingly, HuR overexpression was sufficient to inhibit senescence in BRAF(V600E)-expressing melanocytes and to force their growth. Here, MITF (Microphthalmia-associated transcription factor), a key player in suppressing senescence and an ARE containing transcript, is positively regulated by HuR. Our results show for the first time that the overexpression of HuR is an important part of the regulatory pathway in the development of malignant melanoma and functions as a switch to overcome oncogene-induced senescence and to support melanoma formation. These newly defined alterations may provide possibilities for innovative therapeutic approaches. |
format | Online Article Text |
id | pubmed-7281285 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72812852020-06-19 HuRdling Senescence: HuR Breaks BRAF-Induced Senescence in Melanocytes and Supports Melanoma Growth Liebig, Janika K. Kuphal, Silke Bosserhoff, Anja Katrin Cancers (Basel) Article In addition to genetic changes, post-transcriptional events strongly contribute to the progression of malignant tumors. The RNA-binding protein HuR (ELAVL1) is able to bind and stabilize a large group of target mRNAs, which contain AU-rich elements (ARE) in their 3′-untranslated region. We found HuR to be upregulated in malignant melanoma in vitro and in vivo, significantly correlating with progression in vivo. Additionally, we could show that miR-194-5p can regulate HuR expression level. HuR knockdown in melanoma cells led to the suppression of proliferation and the induction of cellular senescence. Interestingly, HuR overexpression was sufficient to inhibit senescence in BRAF(V600E)-expressing melanocytes and to force their growth. Here, MITF (Microphthalmia-associated transcription factor), a key player in suppressing senescence and an ARE containing transcript, is positively regulated by HuR. Our results show for the first time that the overexpression of HuR is an important part of the regulatory pathway in the development of malignant melanoma and functions as a switch to overcome oncogene-induced senescence and to support melanoma formation. These newly defined alterations may provide possibilities for innovative therapeutic approaches. MDPI 2020-05-21 /pmc/articles/PMC7281285/ /pubmed/32455577 http://dx.doi.org/10.3390/cancers12051299 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Liebig, Janika K. Kuphal, Silke Bosserhoff, Anja Katrin HuRdling Senescence: HuR Breaks BRAF-Induced Senescence in Melanocytes and Supports Melanoma Growth |
title | HuRdling Senescence: HuR Breaks BRAF-Induced Senescence in Melanocytes and Supports Melanoma Growth |
title_full | HuRdling Senescence: HuR Breaks BRAF-Induced Senescence in Melanocytes and Supports Melanoma Growth |
title_fullStr | HuRdling Senescence: HuR Breaks BRAF-Induced Senescence in Melanocytes and Supports Melanoma Growth |
title_full_unstemmed | HuRdling Senescence: HuR Breaks BRAF-Induced Senescence in Melanocytes and Supports Melanoma Growth |
title_short | HuRdling Senescence: HuR Breaks BRAF-Induced Senescence in Melanocytes and Supports Melanoma Growth |
title_sort | hurdling senescence: hur breaks braf-induced senescence in melanocytes and supports melanoma growth |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281285/ https://www.ncbi.nlm.nih.gov/pubmed/32455577 http://dx.doi.org/10.3390/cancers12051299 |
work_keys_str_mv | AT liebigjanikak hurdlingsenescencehurbreaksbrafinducedsenescenceinmelanocytesandsupportsmelanomagrowth AT kuphalsilke hurdlingsenescencehurbreaksbrafinducedsenescenceinmelanocytesandsupportsmelanomagrowth AT bosserhoffanjakatrin hurdlingsenescencehurbreaksbrafinducedsenescenceinmelanocytesandsupportsmelanomagrowth |